137 related articles for article (PubMed ID: 29312507)
1. Metformin inhibits development of diabetic retinopathy through microRNA-497a-5p.
Zhang Y; Chen F; Wang L
Am J Transl Res; 2017; 9(12):5558-5566. PubMed ID: 29312507
[TBL] [Abstract][Full Text] [Related]
2. Metformin inhibits development of diabetic retinopathy through inducing alternative splicing of VEGF-A.
Yi QY; Deng G; Chen N; Bai ZS; Yuan JS; Wu GH; Wang YW; Wu SJ
Am J Transl Res; 2016; 8(9):3947-3954. PubMed ID: 27725874
[TBL] [Abstract][Full Text] [Related]
3. Molecular regulation of ERK5 in development of diabetic retinopathy.
Zhao Q; Wang L; Sun Y; Wang XX
Oncotarget; 2018 Jan; 9(1):1229-1236. PubMed ID: 29416689
[TBL] [Abstract][Full Text] [Related]
4. Prion protein is essential for diabetic retinopathy-associated neovascularization.
Zhu L; Xu J; Liu Y; Gong T; Liu J; Huang Q; Fischbach S; Zou W; Xiao X
Angiogenesis; 2018 Nov; 21(4):767-775. PubMed ID: 29846863
[TBL] [Abstract][Full Text] [Related]
5. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
[TBL] [Abstract][Full Text] [Related]
6. Downregulated HDAC3 or up-regulated microRNA-296-5p alleviates diabetic retinopathy in a mouse model.
Che S; Wu S; Yu P
Regen Ther; 2022 Dec; 21():1-8. PubMed ID: 35619945
[TBL] [Abstract][Full Text] [Related]
7. miR-204-5p promotes diabetic retinopathy development via downregulation of microtubule-associated protein 1 light chain 3.
Mao XB; Cheng YH; Xu YY
Exp Ther Med; 2019 Apr; 17(4):2945-2952. PubMed ID: 30936964
[TBL] [Abstract][Full Text] [Related]
8. [Cell biology of intraocular vascular diseases].
Ishibashi T
Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-384-3p inhibits retinal neovascularization through targeting hexokinase 2 in mice with diabetic retinopathy.
Xia F; Sun JJ; Jiang YQ; Li CF
J Cell Physiol; 2018 Jan; 234(1):721-730. PubMed ID: 30191948
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic Role of
Chen Q; Qiu F; Zhou K; Matlock HG; Takahashi Y; Rajala RVS; Yang Y; Moran E; Ma JX
Diabetes; 2017 Jun; 66(6):1671-1682. PubMed ID: 28270521
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic effect of metformin in mouse oxygen-induced retinopathy is mediated by reducing levels of the vascular endothelial growth factor receptor Flk-1.
Joe SG; Yoon YH; Choi JA; Koh JY
PLoS One; 2015; 10(3):e0119708. PubMed ID: 25785990
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina.
Ling S; Birnbaum Y; Nanhwan MK; Thomas B; Bajaj M; Ye Y
Cell Signal; 2013 Dec; 25(12):2840-7. PubMed ID: 24018047
[TBL] [Abstract][Full Text] [Related]
14. Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy.
Gong Q; Li F; Xie J; Su G
Endocrine; 2019 Jul; 65(1):35-45. PubMed ID: 30980286
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-183 inhibition exerts suppressive effects on diabetic retinopathy by inactivating
Zhang ZZ; Qin XH; Zhang J
Am J Physiol Endocrinol Metab; 2019 Jun; 316(6):E1050-E1060. PubMed ID: 30835506
[TBL] [Abstract][Full Text] [Related]
16. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
[TBL] [Abstract][Full Text] [Related]
17. MiR-20b targets AKT3 and modulates vascular endothelial growth factor-mediated changes in diabetic retinopathy.
Qin B; Liu J; Liu S; Li B; Ren J
Acta Biochim Biophys Sin (Shanghai); 2016 Aug; 48(8):732-40. PubMed ID: 27421659
[TBL] [Abstract][Full Text] [Related]
18. Cell biology of intraocular vascular diseases.
Ishibashi T
Jpn J Ophthalmol; 2000 May; 44(3):323-4. PubMed ID: 10913668
[TBL] [Abstract][Full Text] [Related]
19. Suppression of microRNA-205-5p in human mesenchymal stem cells improves their therapeutic potential in treating diabetic foot disease.
Zhu L; Wang G; Fischbach S; Xiao X
Oncotarget; 2017 Aug; 8(32):52294-52303. PubMed ID: 28881730
[TBL] [Abstract][Full Text] [Related]
20. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
